Dr. Schaffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 2019
- University of RochesterResidency, Internal Medicine, 2013 - 2016
- University of Virginia School of MedicineClass of 2013
Certifications & Licensure
- TN State Medical License 2019 - 2026
- NY State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups.Thomas J Hoffmann, Rebecca E Graff, Ravi K Madduri, Alex A Rodriguez, Clinton L Cario
Nature Genetics. 2025-02-01 - Author Correction: Genetically adjusted PSA levels for prostate cancer screening.Linda Kachuri, Thomas J Hoffmann, Yu Jiang, Sonja I Berndt, John P Shelley
Nature Medicine. 2025-02-01 - 1 citationsTranscriptome-wide association analysis identifies candidate susceptibility genes for prostate-specific antigen levels in men without prostate cancer.Dorothy M Chen, Ruocheng Dong, Linda Kachuri, Thomas J Hoffmann, Yu Jiang
HGG Advances. 2024-07-18
Press Mentions
- Polygenic Risk Score Does Not Improve Prediction of Aggressive Prostate CancerMarch 16th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: